Centennial Wealth Advisory
BMY icon

Centennial Wealth Advisory’s Bristol-Myers Squibb BMY Stock Holding History

Centennial Wealth Advisory’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$250K Sell
3,998
-18
-0.4% -$1.14K 0.05% 175
2026
Q2 		$231K Buy
4,016
+32
+0.8% +$1.84K 0.05% 168
2026
Q1 		$242K Buy
+3,984
New +$232K 0.06% 142

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Centennial Wealth Advisory's BMY Position: Q3 2026 in Review

Centennial Wealth Advisory reduced its Bristol-Myers Squibb (BMY) stake by 0.45% in Q3 2026, selling an estimated $1.14K and leaving 3,998 shares worth $250K. The position accounts for 0.05% of the portfolio, ranked #175.

Centennial Wealth Advisory first reported a position in BMY in Q1 2026 and has held it in 3 quarters since. 762 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Centennial Wealth Advisory held 3,998 shares of Bristol-Myers Squibb worth $250K as of Q3 2026.
  • Centennial Wealth Advisory sold 18 Bristol-Myers Squibb shares in Q3 2026, an estimated $1.14K.
  • Bristol-Myers Squibb made up 0.05% of Centennial Wealth Advisory's portfolio in Q3 2026, its #175 holding.
  • Centennial Wealth Advisory first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 3 quarters since.
  • 762 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Centennial Wealth Advisory's 13F filing for Q3 2026, filed 16 Oct 2026.